UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 1, 2005
Bio Solutions Manufacturing, Inc.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New York
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
000-33229 16-1576984
- --------------------------------------------------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
1161 James Street, Hattiesburg, MS 39401
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(601) 582-4000
- --------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
- ---------------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13(e)-4(c) under the
Exchange Act (17 CFR 240.13e-4(C))
SECTION 1- REGISTRANT'S BUSINESS AND OPERATIONS
Not Applicable
SECTION 2 - FINANCIAL INFORMATION
Not Applicable
SECTION 3 - SECURITIES AND TRADING MARKETS
Not Applicable
SECTION 4 - MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL INFORMATION
Item 4.02 Non-Relience on Previously Issued Finacial Statements or Related or
Audit Report or Completed Interim Review
The Company was advised by the Securities and Exchange Commission by letter
dated September 1, 2005, to which the Company and its independent auditor
agreed, to present financial statements in conformity with Regulation S-B for
comparable fiscal years ended October 31, 2004 and October 31, 2003. The
previously issued financial statements were an audited balance sheet as of
October 31, 2004 and related statement of operations and statement of cash flow
for the period March 1, 2004 through October 31, 2004. This was presented in
comparison to an unaudited balance sheet of the predecessor entity as of
September 30, 2003 and a statement of operations and a statement of cash flow
for the period for the period from October 1, 2002 through September 30, 2003.
Amended financial statements included in the Form 10-KSB/A to be filed on behalf
of the issuer by the close of the week ending December 9, 2005 are for
comparable fiscal years ending October 31, 2004 and October 31, 2003.
Forms 10-QSB filed for the quarters ended January 31, 2005, April 30, 2005
and July 31, 2005 should not be relied upon. Forms 10-QSB/A for the quarters
ended January 31, 2005, April 30, 2005 and July 31, 2005, which incorporate the
adjustments included in the annual financial statements included in Forms
10-KSB/A are being prepared and will be filed shortly.
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Not applicable
SECTION 6 - [Reserved]
Not Applicable
SECTION 7 - REGULATION FD
Not Applicable
SECTION 8 - OTHER EVENTS
Not Applicable
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Bio Solutions Manufacturing, Inc.
---------------------------------
(Registrant)
Date: December 2 , 2005 By: /s/ David S. Bennett
---------------------------------
David S. Bennett
Chief Executive Officer